
Compounded GLP-1 RA drugs: A continuing discussion about GLP-1 RA drugs, the perfect storm of demand and shortages, part 2
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
Scott Brunner, CAE, CEO of the
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.